ASTRAZEN

HealthcareDrug Manufacturers - Specialty & GenericLarge Cap
AstraZeneca Pharma India Limited

AstraZeneca Pharma India Limited (ASTRAZEN), operating in the Healthcare sector as Drug Manufacturers - Specialty & Generic, is a biopharmaceutical company. It manufactures, market...

हिन्दी में

एस्ट्रोजेनेका फार्मा इंडिया लिमिटेड (ASTRAZEN) हेल्थकेयर सेक्टर में ड्रग मैन्युफैक्चरर्स - स्पेशलिटी एंड जेनेरिक के रूप में काम करने वाली एक बायोफार्मास्युटिकल कंपनी है। यह भारत और...

₹5,919+1.40%1D
Previous trading day close · Data updates after market close
1W: -1.0%
1M: -13.7%
6M: -30.8%
1Y: -36.9%
61/100
AverageResearch Score
Market Cap
₹21.1K Cr
Large Cap
P/E Ratio
87.24
Premium
P/B Ratio
16.95
Premium
ROE
15.6%
Decent
ROCE
25.5%
Excellent
Debt / Equity
0.13
Low debt
Div. Yield
0.6%
Low yield
EV/EBITDA
63.17
Expensive
52W Low: ₹5,640Current: ₹5,91952W High: ₹9,849.5
At 7% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
73/100
Growth
Revenue, EPS, profit growth
96/100
Valuation
PE, PB, EV/EBITDA vs sector
15/100
Risk
Debt levels, volatility, coverage
81/100
News Sentiment
Recent news sentiment
0/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
87.24(Premium)
Forward P/E
N/A
P/B Ratio
16.95(Premium)
P/S Ratio
6.08(Expensive)
EV/EBITDA
63.17(Expensive)
Dividend Yield
0.6%
5Y CAGR
18.3%(High growth)
Revenue Growth
29.7%(High)
Profitability
ROE
15.6%(Good)
ROCE
25.5%(Excellent)
ROA
8.9%(Average)
Net Margin
7.0%(Low)
EBITDA Margin
12.6%
Financial Health
Debt to Equity
0.13(Low debt)
Current Ratio
1.91(Healthy)
Quick Ratio
1.13(Good)
Interest Coverage
57.17x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
24(Oversold)
RSI Exp (14)
30(Neutral)
MACD
-338.504(Bearish)
MACD Signal
-318.471
BB Position
22%(Middle)
BB Width
23.40%(High volatility)
ADX (14)
69.4(Very Strong)
Williams %R
-75.0(Neutral)
MFI (14)
15(Oversold)
CCI (20)
-91(Neutral)
Stoch %K
25(Neutral)
ATR (14)
184.21(Avg True Range)
OBV (M)
3.9(Positive)
1W OBV Chg
0.1%(Increasing)
Rel Volume
0.35x(Low activity)
Volatility
31.3%(Moderate)
Max DD 1Y
-45.6%(High loss)
Alpha (CAPM)
-35.25%(Underperforming)
Return vs Nifty
-21.4%(Below Nifty)
EMA 200
7861.3
EMA 50
6858.8
SMA 200
8097.2
vs SMA 50
-15.7%(Below SMA50)
vs SMA 200
-26.9%(Below SMA200)
Volume
4.1K
Avg Vol 3M
0.1L
Shareholding Pattern
Promoter
75.0%
High confidence
FII
2.8%
DII / MF
5.8%
Share ASTRAZEN
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.